Report Categories
View AllRecent Articles
View All
Nni Q4 2025 Earnings Nelnet Inc. Misses Eps Estimates No Revenue Out 20260403 1
Nmrk Stock Analysis Newmark Group Inc. 1.75 Dip To 14.63 Support Level Check 20260403
Evoxu Stock Analysis Evolution Global Acquisition Corp Units Down 0.64 To 10.13 20260403
Cna Stock Analysis Cna Financial Corporation Rises 1.14 Percent To Trade At 46.24 20260403 1
What Could Drag Hertz Htz Stock Lower Price At 5.11 Down 1.35 20260402
Mbly Stock Analysis Mobileye Global Inc Stock Sits At 7.45 With 0.81 Daily Gain 20260403
Shinhan SHG Stock Quarter Start Momentum Building 20260416
TriplePoint TPVG Stock Enter Now Momentum Building 20260418
DAR Darling Ingredients Inc shares drop nearly 4 after Q4 2025 EPS trails analyst estimates by 133
EXFY Expensify Inc rises 258 percent in daily trading despite a large Q4 2025 earnings miss versus analyst estimates
Molecular MOLN Stock What Is Driving Performance Molecular Partners AG ADS notches 325 EPS beat vs estimates
AAR Corp AIR Stock RD Spending Trades Lower 20260416
GLXY Galaxy Digital Inc shares gain nearly six percent despite posting a wider than expected Q4 2025 per share loss
PRI Primerica Inc posts Q4 2025 earnings beat and 66 year over year revenue growth shares dip slightly
Redwood RWTP Stock Trading Hours Trend Strengthens 20260416
Elicio Therapeutics ELTX narrowly tops Q4 2025 EPS estimates shares rise nearly 3 percent in todays trading
Sportswear Sector Catalyst Analysis London Marathon Performance Impact on Brand Equity and Stock Valuation
SBAC SBA delivers 669 percent Q1 2026 EPS surprise yet shares dip 074 percent in daily trading
Mac Mini Market Demand Dynamics Amid Generative AI Agent Adoption Trends
LNSR LENSAR reports widerthanexpected Q4 2025 EPS loss triggering a 297 percent drop in share price today
LBRDK Liberty beats Q3 2025 EPS estimates by nearly 40 percent yet shares fall 806 percent in todays session
PTN Palatin Technologies drops 441 after Q1 2026 EPS comes in 203 below analyst consensus estimates
Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue
OACC Oaktree highlights ongoing life sciences deSPAC target evaluation efforts in latest quarterly earnings update